Analyses of longitudinal effects of gene-environment interactions on plasma C-reactive protein levels: The Hallym Aging Study

Genes and Genomics

Volumn 35, Issue 1, 2013, Pages 131-139

  Hong, Eun Pyo ^a   Kim, Dong Hyun ^a,b   Suh, Jun Gyo ^a   Park, Ji Wan ^a  

^a Hallym University   (South Korea)

^b Hallym University Sacred Heart Hospital   (South Korea)

Author keywords

Cox proportional hazard regression; Gene environment interaction; High sensitivity C reactive protein; Longitudinal effect; Single nucleotide polymorphism; Survival dimensionality reduction

Indexed keywords

APOLIPOPROTEIN E; C REACTIVE PROTEIN; CHOLESTEROL; CYTOCHROME P450 17; CYTOCHROME P450 17A1; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; UNCLASSIFIED DRUG;

AGED; AGING; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; EXERCISE; FEMALE; FOLLOW UP; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEREDITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

EID: 84874417473     PISSN: 19769571     EISSN: 20929293     Source Type: Journal    
DOI: 10.1007/s13258-013-0093-5     Document Type: Article

References (31)

1. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265
2. Beretta L, Santaniello A, van Riel PL, Coenen MJ, Scorza R (2010) Survival dimensionality reduction (SDR): development and clinical application of an innovative approach to detect epistasis in presence of right-censored data. BMC Bioinformatics 11:416
3. Chasman DI, Kozlowski P, Zee RY, Kwiatkowski DJ, Ridker PM (2006) Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein, LDL-cholesterol, and apoE protein. Genes Immun 7:211-219
4. Choi EY, Park EH, Cheong YS, Rheem I, Park SG, Yoo S (2006) Association of C-reactive protein with the metabolic risk factors among young and middle-aged Koreans. Metabolism 55:415-421
5. Dehghan A, Dupuis J, Barbalic M, Bis JC, Eiriksdottir G, Lu C, Pellikka N, Wallaschofski H, Kettunen J, Henneman P et al (2011) Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123:731-738
6. Eiriksdottir G, Smith AV, Aspelund T, Hafsteinsdottir SH, Olafsdottir E, Launer LJ, Harris TB, Gudnason V (2009) The interaction of adiposity with the CRP gene affects CRP levels: age, gene/environment susceptibility-Reykjavik study. Int J Obes (Lond) 33:267-272
7. Elliott P, Chambers JC, Zhang W, Clarke R, Hopewell JC, Peden JF, Erdmann J, Braund P, Engert JC, Bennett D et al (2009) Genetic loci associated with C-reactive protein levels and risk of coronary heart disease. JAMA 302:37-48
8. Gimeno-Orna JA, Faure-Nogueras E, Sancho-Serrano MA (2005) Usefulness of total cholesterol/HDL-cholesterol ratio in the management of diabetic dyslipidaemia. Diabet Med 22:26-31
9. Gui J, Moore JH, Kelsey KT, Marsit CJ, Karagas MR, Andrew AS (2011) A novel survival multifactor dimensionality reduction method for detecting gene-gene interactions with application to bladder cancer prognosis. Hum Genet 129:101-110
10. Hahn LW, Ritchie MD, Moore JH (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19:376-382
11. Hsu LA, Ko YL, Teng MS, Wu S, Chou HH, Chang PY, Chang HH (2011) Effect of obesity on the association between common variations in the HNF1A gene region and C-reactive protein level in Taiwanese. Clin Chim Acta 412:725-729
12. Huffman FG, Whisner S, Zarini GG, Nath S (2010) Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hsCRP) in Cuban Americans with and without type 2 diabetes. Int J Environ Res Public Health 7:842-852
13. Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney JF Jr, Wilson PW, Newton-Cheh C, Musone SL, Camargo AL et al (2006) Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113:1415-1423
14. Kong M and Lee C (2012) Genetic associations with C-reactive protein level and white blood cell count in the KARE study. Int J Immunogenet 2012 Jul 13 [Epub ahead of print]
15. Liu C, Li H, Qi Q, Lu L, Gan W, Loos RJ, Lin X (2011) Common variants in or near FGF5, CYP17A1 and MTHFR genes are associated with blood pressure and hypertension in Chinese Hans. J Hypertens 29:70-75
16. Mahley RW, Rall SC Jr (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1:507-537
17. Mohás M, Kisfali P, Járomi L, Maász A, Fehér E, Csöngei V, Polgár N, Sáfrány E, Cseh J, Sümegi K et al (2010) GCKR gene functional variants in type 2 diabetes and metabolic syndrome: do the rare variants associate with increased carotid intima-media thickness? Cardiovasc Diabetol 9:79
18. Pai JK, Pischon T, Ma J, Manson JE, Hankinson SE, Joshipura K, Curhan GC, Rifai N, Cannuscio CC, Stampfer MJ et al (2004) Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351:2599-2610
19. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL et al (2003) Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511
20. Reiner AP, Gross MD, Carlson CS, Bielinski SJ, Lange LA, Fornage M, Jenny NS, Walston J, Tracy RP, Williams OD et al (2009) Common coding variants of the HNF1A gene are associated with multiple cardiovascular risk phenotypes in community-based samples of younger and older European-American adults: the Coronary Artery Risk Development in Young Adults Study and The Cardiovascular Health Study. Circ Cardiovasc Genet 2:244-254
21. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342:836-843
22. Ridker PM, Pare G, Parker A, Zee RY, Danik JS, Buring JE, Kwiatkowski D, Cook NR, Miletich JP, Chasman DI (2008) Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study. Am J Hum Genet 82:1185-1192
23. Saijo Y, Yoshioka E, Fukui T, Kawaharada M, Sata F, Sato H, Kishi R (2007) Effects of the Interaction between Interleukin-6 -634C/G polymorphism and smoking on serum C-reactive protein concentrations. Hypertens Res 30:593-599
24. Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, Gorman DN, Gao P, Saleheen D, Rendon A, Nelson CP et al (2012) Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet 379:1205-1213
25. Tan Q, Christiansen L, Bathum L, Li S, Kruse TA, Christensen K (2006) Genetic association analysis of human longevity in cohort studies of elderly subjects: an example of the PON1 gene in the Danish 1905 birth cohort. Genetics 172:1821-1828
26. Tang MX, Maestre G, Tsai WY, Liu XH, Feng L, Chung WY, Chun M, Schofield P, Stern Y, Tycko B et al (1996) Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City. Am J Hum Genet 58:574-584
27. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, Kuller LH (1997) Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol 17:2167-2176
28. Vaxillaire M, Cavalcanti-Proença C, Dechaume A, Tichet J, Marre M, Balkau B, Froguel P (2008) The common P446L polymorphism in GCKR inversely modulates fasting glucose and triglyceride levels and reduces type 2 diabetes risk in the DESIR prospective general french population. Diabetes 57:2253-2257
29. Verma S, Szmitko PE, Ridker PM (2005) C-reactive protein comes of age. Nat Clin Pract Cardiovasc Med 2:29-36
30. Wu Y, McDade TW, Kuzawa CW, Borja J, Li Y, Adair LS, Mohlke KL, Lange LA (2012) Genome-wide association with C-reactive protein levels in CLHNS: evidence for the CRP and HNF1A loci and their interaction with exposure to a pathogenic environment. Inflammation 35:574-583
31. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV et al (1996) Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458